These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27846946)

  • 21. Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis.
    Bianchi L; Del Duca E; Romanelli M; Saraceno R; Chimenti S; Chiricozzi A
    Expert Opin Drug Metab Toxicol; 2016 Sep; 12(9):1121-8. PubMed ID: 27376729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Otezla, Warts and All, Racks Up Sales and Eyes Blockbuster Status.
    Reinke T
    Manag Care; 2017 Oct; 26(10):8-9. PubMed ID: 29068290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apremilast: A Review in Psoriasis and Psoriatic Arthritis.
    Deeks ED
    Drugs; 2015 Aug; 75(12):1393-403. PubMed ID: 26220911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging Oral Immunomodulators for the Treatment of Psoriasis: A Review of Phase III Clinical Trials for Apremilast and Tofacitinib.
    McAndrew R; Levin E; Koo J
    J Drugs Dermatol; 2015 Aug; 14(8):786-92. PubMed ID: 26267722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1).
    Papp K; Reich K; Leonardi CL; Kircik L; Chimenti S; Langley RG; Hu C; Stevens RM; Day RM; Gordon KB; Korman NJ; Griffiths CE
    J Am Acad Dermatol; 2015 Jul; 73(1):37-49. PubMed ID: 26089047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apremilast in psoriatic arthritis.
    Schett G
    Clin Exp Rheumatol; 2015; 33(5 Suppl 93):S98-100. PubMed ID: 26472278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Gastrointestinal side effects of apremilast : Characterization and management].
    Pinter A; Beigel F; Körber A; Homey B; Beissert S; Gerdes S; Staubach-Renz P; Radtke MA; Mössner R
    Hautarzt; 2019 May; 70(5):354-362. PubMed ID: 30937481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A review of phosphodiesterase-inhibition and the potential role for phosphodiesterase 4-inhibitors in clinical dermatology.
    Moustafa F; Feldman SR
    Dermatol Online J; 2014 May; 20(5):22608. PubMed ID: 24852768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel Oral Therapies for Psoriasis and Psoriatic Arthritis.
    Yiu ZZ; Warren RB
    Am J Clin Dermatol; 2016 Jun; 17(3):191-200. PubMed ID: 26923915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multidisciplinary Management of the Adverse Effects of Apremilast.
    Daudén Tello E; Alonso Suárez J; Beltrán Catalán E; Blasco Maldonado C; Herrero Manso MC; Jiménez Morales A; Marín-Jiménez I; Martín-Arranz MD; García-Merino A; Porta Etessam J; Rodríguez-Sagrado MA; Rosas Gómez de Salazar J; Trujillo Martín E; Salgado-Boquete L
    Actas Dermosifiliogr (Engl Ed); 2021 Feb; 112(2):134-141. PubMed ID: 32910923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longterm (52-week) results of a phase III randomized, controlled trial of apremilast in patients with psoriatic arthritis.
    Kavanaugh A; Mease PJ; Gomez-Reino JJ; Adebajo AO; Wollenhaupt J; Gladman DD; Hochfeld M; Teng LL; Schett G; Lespessailles E; Hall S
    J Rheumatol; 2015 Mar; 42(3):479-88. PubMed ID: 25593233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apremilast as a treatment for psoriasis.
    Shutty B; West C; Pellerin M; Feldman S
    Expert Opin Pharmacother; 2012 Aug; 13(12):1761-70. PubMed ID: 22712800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Real-world, single-centre experience of apremilast for the treatment of moderate to severe psoriasis.
    Wong TH; Sinclair S; Smith B; Fraser C; Morton CA
    Clin Exp Dermatol; 2017 Aug; 42(6):675-676. PubMed ID: 28621002
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate-to-severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2).
    Paul C; Cather J; Gooderham M; Poulin Y; Mrowietz U; Ferrandiz C; Crowley J; Hu C; Stevens RM; Shah K; Day RM; Girolomoni G; Gottlieb AB
    Br J Dermatol; 2015 Dec; 173(6):1387-99. PubMed ID: 26357944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Real life experience of apremilast in psoriasis and arthritis psoriatic patients: Preliminary results on metabolic biomarkers.
    Mazzilli S; Lanna C; Chiaramonte C; Cesaroni GM; Zangrilli A; Palumbo V; Cosio T; Dattola A; Gaziano R; Galluzzo M; Chimenti MS; Gisondi P; Bianchi L; Campione E
    J Dermatol; 2020 Jun; 47(6):578-582. PubMed ID: 32239555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apremilast (otezla) for psoriatic arthritis.
    Med Lett Drugs Ther; 2014 May; 56(1443):41-2. PubMed ID: 24869713
    [No Abstract]   [Full Text] [Related]  

  • 37. Three cases of palmoplantar pustulosis successfully treated with apremilast.
    Eto A; Nakao M; Furue M
    J Dermatol; 2019 Jan; 46(1):e29-e30. PubMed ID: 29905386
    [No Abstract]   [Full Text] [Related]  

  • 38. A phase 2, open-label, investigator-initiated study to evaluate the safety and efficacy of apremilast in subjects with recalcitrant allergic contact or atopic dermatitis.
    Volf EM; Au SC; Dumont N; Scheinman P; Gottlieb AB
    J Drugs Dermatol; 2012 Mar; 11(3):341-6. PubMed ID: 22395585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-World Experience With Apremilast in Treating Psoriasis.
    Mayba JN; Gooderham MJ
    J Cutan Med Surg; 2017; 21(2):145-151. PubMed ID: 27846617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple lentigines arising in resolving psoriatic plaques after treatment with etanercept.
    Costa LA; Belinchón I; Betlloch I; Pérez-Crespo M; Mataix J
    Dermatol Online J; 2008 Jan; 14(1):11. PubMed ID: 18319028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.